{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T09:27:03Z","timestamp":1791624423592,"version":"4.3.4"},"reference-count":105,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"am","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000291","name":"Kidney Research UK","doi-asserted-by":"publisher","award":["RP_001_20180925"],"award-info":[{"award-number":["RP_001_20180925"]}],"id":[{"id":"10.13039\/501100000291","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004185","name":"Northern Counties Kidney Research Fund","doi-asserted-by":"publisher","award":["20\/01"],"award-info":[{"award-number":["20\/01"]}],"id":[{"id":"10.13039\/501100004185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"MRC","doi-asserted-by":"publisher","award":["MR\/Y007808\/1"],"award-info":[{"award-number":["MR\/Y007808\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R01HG011799"],"award-info":[{"award-number":["R01HG011799"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.semnephrol.2025.151651","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T13:09:55Z","timestamp":1752584995000},"page":"151651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Using Large Genomic Biobanks to Generate Insights into Genetic Kidney Disease"],"prefix":"10.1016","volume":"45","author":[{"given":"Alexander R.","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janewit","family":"Wongboonsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Mallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Retterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tooraj","family":"Mirshahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Sayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.semnephrol.2025.151651_bib0001","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","article-title":"Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data","volume":"3","author":"Matsushita","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.semnephrol.2025.151651_bib0002","series-title":"2022 USRDS annual data report: Epidemiology of kidney disease in the United States","year":"2022"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151651_bib0003","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1097\/01.ASN.0000135972.13396.6F","article-title":"Genomewide linkage analysis to serum creatinine, GFR, and creatinine clearance in a community-based population: the Framingham Heart Study","volume":"15","author":"Fox","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151651_bib0004","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.kint.2022.03.019","article-title":"Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","volume":"101","author":"K\u00f6ttgen","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.semnephrol.2025.151651_bib0005","unstructured":"Annual Data Report | USRDS. Accessed February 17, 2025. https:\/\/usrds-adr.niddk.nih.gov\/2024"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151651_bib0006","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.ekir.2022.05.012","article-title":"The heritability of kidney function using an older australian twin population","volume":"7","author":"Jefferis","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151651_bib0007","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.2215\/CJN.11971018","article-title":"Genetic and environmental influences on the correlations between traits of metabolic syndrome and CKD","volume":"14","author":"Chen","year":"2019","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7831","key":"10.1016\/j.semnephrol.2025.151651_bib0008","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41586-020-2853-0","article-title":"Exome sequencing and characterization of 49,960 individuals in the UK Biobank","volume":"586","author":"Van Hout","year":"2020","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151651_bib0009","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/gim.2015.187","article-title":"The Geisinger MyCode community health initiative: an electronic health record-linked biobank for precision medicine research","volume":"18","author":"Carey","year":"2016","journal-title":"Genet Med"},{"issue":"6319","key":"10.1016\/j.semnephrol.2025.151651_bib0010","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf6814","article-title":"Distribution and clinical impact of functional variants in 50,726 whole-exome sequences from the DiscovEHR study","volume":"354","author":"Dewey","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.semnephrol.2025.151651_bib0011","article-title":"The 100 000 Genomes Project: bringing whole genome sequencing to the NHS","volume":"361","author":"Turnbull","year":"2018","journal-title":"BMJ"},{"issue":"7769","key":"10.1016\/j.semnephrol.2025.151651_bib0012","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41586-019-1457-z","article-title":"Exome sequencing of Finnish isolates enhances rare-variant association power","volume":"572","author":"Locke","year":"2019","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151651_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.xgen.2023.100361","article-title":"Genotyping and population characteristics of the China Kadoorie Biobank","volume":"3","author":"Walters","year":"2023","journal-title":"Cell Genomics"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151651_bib0014","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1056\/NEJMsr1809937","article-title":"The \u201cAll of Us\u201d research program","volume":"381","year":"2019","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151651_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-022-34116-9","article-title":"Analysis of clinically relevant variants from ancestrally diverse Asian genomes","volume":"13","author":"Chan","year":"2022","journal-title":"Nature Communications"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151651_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.xgen.2022.100197","article-title":"Taiwan Biobank: a rich biomedical research database of the Taiwanese population","volume":"2","author":"Feng","year":"2022","journal-title":"Cell Genomics"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151651_bib0017","doi-asserted-by":"crossref","DOI":"10.1186\/s13073-023-01235-x","article-title":"Building blocks for better biorepositories in Africa","volume":"15","author":"Croxton","year":"2023","journal-title":"Genome Med"},{"issue":"8012","key":"10.1016\/j.semnephrol.2025.151651_bib0018","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/s41586-024-07316-0","article-title":"Refining the impact of genetic evidence on clinical success","volume":"629","author":"Minikel","year":"2024","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151651_bib0019","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ajhg.2017.06.005","article-title":"10 Years of GWAS discovery: biology, function, and translation","volume":"101","author":"Visscher","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151651_bib0020","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1161\/CIRCRESAHA.118.311227","article-title":"PCSK9: from basic science discoveries to clinical trials","volume":"122","author":"Shapiro","year":"2018","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151651_bib0021","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat Genet"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151651_bib0022","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng1509","article-title":"Low LDL cholesterol in individuals of African descent resulting from frequent nonsense mutations in PCSK9","volume":"37","author":"Cohen","year":"2005","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151651_bib0023","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151651_bib0024","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1038\/s41588-018-0222-9","article-title":"Genetics of blood lipids among \u223c300,000 multi-ethnic participants of the Million Veteran Program","volume":"50","author":"Klarin","year":"2018","journal-title":"Nat Genet"},{"issue":"18","key":"10.1016\/j.semnephrol.2025.151651_bib0025","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.semnephrol.2025.151651_bib0026","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"issue":"7988","key":"10.1016\/j.semnephrol.2025.151651_bib0027","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/d41586-023-03543-z","article-title":"First trial of \u201cbase editing\u201d in humans lowers cholesterol - but raises safety concerns","volume":"623","author":"Naddaf","year":"2023","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151651_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-023-37465-1","article-title":"GalNAc-lipid nanoparticles enable non-LDLR dependent hepatic delivery of a CRISPR base editing therapy","volume":"14","author":"Kasiewicz","year":"2023","journal-title":"Nat Comm"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151651_bib0029","doi-asserted-by":"crossref","first-page":"294","DOI":"10.2215\/CJN.15161219","article-title":"Apol1 nephropathy: from genetics to clinical applications","volume":"16","author":"Friedman","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5993","key":"10.1016\/j.semnephrol.2025.151651_bib0030","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1126\/science.1193032","article-title":"Association of trypanolytic ApoL1 variants with kidney disease in African Americans","volume":"329","author":"Genovese","year":"2010","journal-title":"Science"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151651_bib0031","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.2011040388","article-title":"APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy","volume":"22","author":"Kopp","year":"2011","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151651_bib0032","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00439-010-0861-0","article-title":"Missense mutations in the APOL1 gene are highly associated with end stage kidney disease risk previously attributed to the MYH9 gene","volume":"128","author":"Tzur","year":"2010","journal-title":"Hum Genet"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151651_bib0033","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1681\/ASN.2013010113","article-title":"APOL1 variants associate with increased risk of CKD among African Americans","volume":"24","author":"Foster","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151651_bib0034","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1681\/ASN.2015020124","article-title":"APOL1 genotype and race differences in incident albuminuria and renal function decline","volume":"27","author":"Peralta","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151651_bib0035","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1681\/ASN.2015070763","article-title":"Race, APOL1 risk, and eGFR decline in the general population","volume":"27","author":"Grams","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151651_bib0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-023-43020-9","article-title":"Strong protective effect of the APOL1 p.N264K variant against G2-associated focal segmental glomerulosclerosis and kidney disease","volume":"14","author":"Gupta","year":"2023","journal-title":"Nat Comm"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151651_bib0037","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-024-55408-2","article-title":"Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney disease","volume":"16","author":"Zimmerman","year":"2025","journal-title":"Nat Comm"},{"issue":"6734","key":"10.1016\/j.semnephrol.2025.151651_bib0038","article-title":"Kidney multiome-based genetic scorecard reveals convergent coding and regulatory variants","volume":"387","author":"Liu","year":"2025","journal-title":"Science (1979)"},{"key":"10.1016\/j.semnephrol.2025.151651_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.trac.2023.116954","article-title":"Advances in high throughput LC\/MS based metabolomics: a review","volume":"160","author":"Plumb","year":"2023","journal-title":"TrAC Trends Analyt Chem"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151651_bib0040","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/s41374-022-00830-7","article-title":"High-throughput proteomics: a methodological mini-review","volume":"102","author":"Cui","year":"2022","journal-title":"Lab Investigat"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151651_bib0041","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1053\/j.ajkd.2017.12.008","article-title":"How omics data can be used in nephrology","volume":"72","author":"Rhee","year":"2018","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151651_bib0042","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/s41588-019-0407-x","article-title":"A catalog of genetic loci associated with kidney function from analyses of a million individuals","volume":"51","author":"Wuttke","year":"2019","journal-title":"Nat Genet"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151651_bib0043","doi-asserted-by":"crossref","first-page":"3161","DOI":"10.1681\/ASN.2020111599","article-title":"Polygenic risk scores for kidney function and their associations with circulating proteome, and incident kidney diseases","volume":"32","author":"Yu","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151651_bib0044","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-023-43878-9","article-title":"Polygenic risk alters the penetrance of monogenic kidney disease","volume":"14","author":"Khan","year":"2023","journal-title":"Nat Comm"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151651_bib0045","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/s41591-022-01869-1","article-title":"Genome-wide polygenic score to predict chronic kidney disease across ancestries","volume":"28","author":"Khan","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.semnephrol.2025.151651_bib0046","article-title":"The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis","volume":"352","author":"Hollands","year":"2016","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151651_bib0047","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/tbm\/ibac071","article-title":"Returning complex genetic risk information to promote better health-related behaviors: a commentary of the literature and suggested next steps","volume":"13","author":"Driver","year":"2022","journal-title":"Transl Behav Med"},{"key":"10.1016\/j.semnephrol.2025.151651_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2018.00047","article-title":"Update on hereditary kidney stone disease and introduction of a new clinical patient registry in Germany","volume":"6","author":"Halbritter","year":"2018","journal-title":"Front Pediatr"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151651_bib0049","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.1048","article-title":"Effects of testing and disclosing ancestry-specific genetic risk for kidney failure on patients and health care professionals: a randomized clinical trial","volume":"5","author":"Nadkarni","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151651_bib0050","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41591-024-02796-z","article-title":"Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations","volume":"30","author":"Lennon","year":"2024","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151651_bib0051","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11112-0","article-title":"Analysis of polygenic risk score usage and performance in diverse human populations","volume":"10","author":"Duncan","year":"2019","journal-title":"Nat Commun"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151651_bib0052","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1093\/ndt\/gfae074","article-title":"Prevalence and characteristics of genetic disease in adult kidney stone formers","volume":"39","author":"Anderegg","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151651_bib0053","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1681\/ASN.2014040388","article-title":"Fourteen monogenic genes account for 15% of nephrolithiasis\/nephrocalcinosis","volume":"26","author":"Halbritter","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151651_bib0054","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms8975","article-title":"Common and rare variants associated with kidney stones and biochemical traits","volume":"6","author":"Oddsson","year":"2015","journal-title":"Nat Commun"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151651_bib0055","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ng.568","article-title":"New loci associated with kidney function and chronic kidney disease","volume":"42","author":"K\u00f6ttgen","year":"2010","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151651_bib0056","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.kint.2024.08.035","article-title":"Presentation and outcome in carriers of pathogenic variants in SLC34A1 and SLC34A3 encoding sodium-phosphate transporter NPT 2a and 2c","volume":"107","author":"Brunkhorst","year":"2024","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151651_bib0057","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.kint.2023.06.019","article-title":"Rare variants in the sodium-dependent phosphate transporter gene SLC34A3 explain missing heritability of urinary stone disease","volume":"104","author":"Sadeghi-Alavijeh","year":"2023","journal-title":"Kidney Int"},{"issue":"7899","key":"10.1016\/j.semnephrol.2025.151651_bib0058","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41586-022-04394-w","article-title":"Genetic associations of protein-coding variants in human disease","volume":"603","author":"Sun","year":"2022","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151651_bib0059","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1681\/ASN.2014101025","article-title":"Autosomal-recessive mutations in SLC34A1 encoDing sodium-phosphate cotransporter 2a cause idiopathic infantile hypercalcemia","volume":"27","author":"Schlingmann","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151651_bib0060","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.ajhg.2022.09.014","article-title":"Reduced penetrance of MODY-associated HNF1A\/HNF4A variants but not GCK variants in clinically unselected cohorts","volume":"109","author":"Mirshahi","year":"2022","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151651_bib0061","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2024.07.009","article-title":"KDIGO 2025 clinical practice guideline for the evaluation, management, and treatment of autosomal dominant polycystic kidney disease (ADPKD)","volume":"107","author":"Devuyst","year":"2025","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151651_bib0062","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1093\/ndt\/gfw240","article-title":"Prevalence of autosomal dominant polycystic kidney disease in the European Union","volume":"32","author":"Willey","year":"2017","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151651_bib0063","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.34067\/KID.0004522021","article-title":"Autosomal dominant polycystic kidney disease prevalence among a racially diverse United States population, 2002 through 2018","volume":"2","author":"Aung","year":"2021","journal-title":"Kidney 360"},{"issue":"24","key":"10.1016\/j.semnephrol.2025.151651_bib0064","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1001\/jama.2022.22847","article-title":"Exome sequencing of a clinical population for autosomal dominant polycystic kidney disease","volume":"328","author":"Chang","year":"2022","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151651_bib0065","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1038\/s41436-018-0324-x","article-title":"Population data improves variant interpretation in autosomal dominant polycystic kidney disease","volume":"21","author":"Mallawaarachchi","year":"2019","journal-title":"Genet Med"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151651_bib0066","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1681\/ASN.2019030298","article-title":"ALG9 mutation carriers develop kidney and liver cysts","volume":"30","author":"Besse","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151651_bib0067","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ajhg.2021.11.016","article-title":"Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype","volume":"109","author":"Senum","year":"2022","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151651_bib0068","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.kint.2022.11.025","article-title":"Individuals heterozygous for ALG8 protein-truncating variants are at increased risk of a mild cystic kidney disease","volume":"103","author":"Apple","year":"2023","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151651_bib0069","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/j.ajhg.2022.06.013","article-title":"Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis","volume":"109","author":"Lemoine","year":"2022","journal-title":"Am J Hum Genet"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151651_bib0070","first-page":"1241","article-title":"X-linked inheritance of Alport syndrome: family P revisited","volume":"35","author":"Hasstedt","year":"1983","journal-title":"Am J Hum Genet"},{"issue":"11","key":"10.1016\/j.semnephrol.2025.151651_bib0071","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1651-2227.1996.tb13915.x","article-title":"Alport\u2019s syndrome in 78 patients: epidemiological and clinical study","volume":"85","author":"Pajari","year":"1996","journal-title":"Acta Paediatr"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151651_bib0072","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1681\/ASN.2020071065","article-title":"Prevalence estimates of predicted pathogenic COL4A3-COL4A5 variants in a population sequencing database and their implications for Alport syndrome","volume":"32","author":"Gibson","year":"2021","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2025.151651_bib0073","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ajhg.2023.01.018","article-title":"Australian genomics: outcomes of a 5-year national program to accelerate the integration of genomics in healthcare","volume":"110","author":"Stark","year":"2023","journal-title":"Am J Hum Genet"},{"issue":"8","key":"10.1016\/j.semnephrol.2025.151651_bib0074","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12081323","article-title":"The evolution of a large biobank at Mass General Brigham","volume":"12","author":"Boutin","year":"2022","journal-title":"J Pers Med"},{"issue":"7","key":"10.1016\/j.semnephrol.2025.151651_bib0075","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00467-018-3985-4","article-title":"Expert consensus guidelines for the genetic diagnosis of Alport syndrome","volume":"34","author":"Savige","year":"2019","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.semnephrol.2025.151651_bib0076","doi-asserted-by":"crossref","DOI":"10.1007\/s00467-025-06702-8","article-title":"Cracking the code: an integrated electronic medical record approach to early diagnosis of genetic kidney disease in children with microscopic haematuria","author":"Butler","year":"2025","journal-title":"Pediatr Nephrol."},{"issue":"10","key":"10.1016\/j.semnephrol.2025.151651_bib0077","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.ekir.2023.07.010","article-title":"The phenotypic spectrum of COL4A3 heterozygotes","volume":"8","author":"Solanki","year":"2023","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.semnephrol.2025.151651_bib0078","doi-asserted-by":"crossref","DOI":"10.1101\/2024.06.04.24308453","article-title":"Genotype-first analysis in an unselected health system\u2013based population and phenotypic severity of COL4A5 variants","author":"Zellers","year":"2024","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151651_bib0079","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1046\/j.1523-1755.2003.00779.x","article-title":"Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome","volume":"63","author":"Gross","year":"2003","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151651_bib0080","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/ki.2011.407","article-title":"Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy","volume":"81","author":"Gross","year":"2012","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151651_bib0081","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.kint.2019.12.015","article-title":"A multicenter, randomized, placebo-controlled, double-blind phase 3 trial with open-arm comparison indicates safety and efficacy of nephroprotective therapy with ramipril in children with Alport\u2019s syndrome","volume":"97","author":"Gross","year":"2020","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151651_bib0082","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.kint.2020.06.038","article-title":"Genotype-phenotype correlations influence the response to angiotensin-targeting drugs in Japanese patients with male X-linked Alport syndrome","volume":"98","author":"Yamamura","year":"2020","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151651_bib0083","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1093\/ndt\/gfac006","article-title":"Lifelong effect of therapy in young patients with the COL4A5 Alport missense variant p.(Gly624Asp): a prospective cohort study","volume":"37","author":"Boeckhaus","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151651_bib0084","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1056\/NEJMoa1806891","article-title":"Diagnostic utility of exome sequencing for kidney disease","volume":"380","author":"Groopman","year":"2019","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151651_bib0085","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1681\/ASN.2019020152","article-title":"Contributions of rare gene variants to familial and sporadic FSGS","volume":"30","author":"Wang","year":"2019","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151651_bib0086","doi-asserted-by":"crossref","first-page":"900","DOI":"10.34067\/KID.0004162021","article-title":"The KIDNEYCODE program: diagnostic yield and clinical features of individuals with CKD","volume":"3","author":"Lieberman","year":"2022","journal-title":"Kidney 360"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151651_bib0087","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1681\/ASN.0000000000000249","article-title":"The clinical utility of genetic testing in the diagnosis and management of adults with chronic kidney disease","volume":"34","author":"Dahl","year":"2023","journal-title":"J Am Soc Nephrol"},{"issue":"50","key":"10.1016\/j.semnephrol.2025.151651_bib0088","doi-asserted-by":"crossref","first-page":"38117","DOI":"10.1074\/jbc.R600025200","article-title":"Molecular recognition in the assembly of collagens: terminal noncollagenous domains are key recognition modules in the formation of triple helical protomers","volume":"281","author":"Khoshnoodi","year":"2006","journal-title":"J Biol Chem"},{"issue":"39","key":"10.1016\/j.semnephrol.2025.151651_bib0089","doi-asserted-by":"crossref","first-page":"30716","DOI":"10.1074\/jbc.M004569200","article-title":"Type IV collagen of the glomerular basement membrane: evidence that the chain specificity of network assembly is encoded by the noncollagenous NC1 domains","volume":"275","author":"Boutaud","year":"2000","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151651_bib0090","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2215\/CJN.0000000000000564","article-title":"Utility of genetic testing in adults with CKD: a systematic review and meta-analysis","volume":"20","author":"Schott","year":"2025","journal-title":"Clin J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151651_bib0091","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.kint.2018.10.031","article-title":"Monogenic causes of chronic kidney disease in adults","volume":"95","author":"Connaughton","year":"2019","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151651_bib0092","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/s41436-020-00963-4","article-title":"Clinical impact of genomic testing in patients with suspected monogenic kidney disease","volume":"23","author":"Jayasinghe","year":"2021","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151651_bib0093","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.kint.2017.06.013","article-title":"Massively parallel sequencing and targeted exomes in familial kidney disease can diagnose underlying genetic disorders","volume":"92","author":"Mallett","year":"2017","journal-title":"Kidney Int"},{"issue":"12","key":"10.1016\/j.semnephrol.2025.151651_bib0094","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.100947","article-title":"The landscape of reported VUS in multi-gene panel and genomic testing: time for a change","volume":"25","author":"Rehm","year":"2023","journal-title":"Genet Med"},{"issue":"6","key":"10.1016\/j.semnephrol.2025.151651_bib0095","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.118.002169","article-title":"Variants of uncertain significance: should we revisit how they are evaluated and disclosed?","volume":"11","author":"Morales","year":"2018","journal-title":"Circ Genom Precis Med"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151651_bib0096","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.gim.2021.10.010","article-title":"Reanalysis of eMERGE phase III sequence variants in 10,500 participants and infrastructure to support the automated return of knowledge updates","volume":"24","author":"Zouk","year":"2022","journal-title":"Genet Med"},{"issue":"4","key":"10.1016\/j.semnephrol.2025.151651_bib0097","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000522226","article-title":"Genetic etiologies for chronic kidney disease revealed through next-generation renal gene panel","volume":"53","author":"Bleyer","year":"2022","journal-title":"Am J Nephrol"},{"issue":"5","key":"10.1016\/j.semnephrol.2025.151651_bib0098","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ajt.2023.02.020","article-title":"Genetic evaluation of living kidney donor candidates: a review and recommendations for best practices","volume":"23","author":"Thomas","year":"2023","journal-title":"Am J Transplant"},{"key":"10.1016\/j.semnephrol.2025.151651_bib0099","doi-asserted-by":"crossref","DOI":"10.1053\/j.ajkd.2024.05.010","article-title":"Advancing genetic testing in kidney diseases: report from a National Kidney Foundation Working Group","author":"Franceschini","year":"2024","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151651_bib0100","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1016\/j.ekir.2022.06.014","article-title":"Framework from a multidisciplinary approach for transitioning variants of unknown significance from clinical genetic testing in kidney disease to a definitive classification","volume":"7","author":"Mirshahi","year":"2022","journal-title":"Kidney Int Rep"},{"issue":"9","key":"10.1016\/j.semnephrol.2025.151651_bib0101","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/aje\/kwx246","article-title":"Comparison of sociodemographic and health-related characteristics of UK biobank participants with those of the general population","volume":"186","author":"Fry","year":"2017","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.semnephrol.2025.151651_bib0102","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.883073","article-title":"A RE-AIM framework analysis of DNA-based population screening: using implementation science to translate research into practice in a healthcare system","volume":"13","author":"Jones","year":"2022","journal-title":"Front Genet"},{"issue":"1","key":"10.1016\/j.semnephrol.2025.151651_bib0103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s44162-025-00067-0","article-title":"Genomic diversity: meeting the challenge of rare diseases","volume":"4","author":"Soliman","year":"2025","journal-title":"J Rare Disease"},{"key":"10.1016\/j.semnephrol.2025.151651_bib0104","first-page":"1","article-title":"Genomic data in the All of Us Research Program","author":"Bick","year":"2024","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.semnephrol.2025.151651_bib0105","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41576-024-00776-0","article-title":"A call to action to scale up research and clinical genomic data sharing","volume":"26","author":"Stark","year":"2024","journal-title":"Nat Rev Genetics"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929525000865?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929525000865?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T09:22:14Z","timestamp":1777540934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929525000865"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":105,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0270929525000865"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2025.151651","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using Large Genomic Biobanks to Generate Insights into Genetic Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2025.151651","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151651"}}